Translate text to:
In JoVE (1)
Other Publications (2)
Articles by Yaqiu Li in JoVE
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
Sara Lynn N. Farwell1, Joshua B. Slee2, Yaqiu Li1, Linda J. Lowe-Krentz1
1Department of Biological Sciences, Lehigh University, 2Department of Natural Science, DeSales University
Other articles by Yaqiu Li on PubMed
Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin
The Journal of Biological Chemistry. Mar, 2016 | Pubmed ID: 26769966
Vascular cell responses to exogenous heparin have been documented to include decreased vascular smooth muscle cell proliferation following decreased ERK pathway signaling. However, the molecular mechanism(s) by which heparin interacts with cells to induce those responses has remained unclear. Previously characterized monoclonal antibodies that block heparin binding to vascular cells have been found to mimic heparin effects. In this study, those antibodies were employed to isolate a heparin binding protein. MALDI mass spectrometry data provide evidence that the protein isolated is transmembrane protein 184A (TMEM184A). Commercial antibodies against three separate regions of the TMEM184A human protein were used to identify the TMEM184A protein in vascular smooth muscle cells and endothelial cells. A GFP-TMEM184A construct was employed to determine colocalization with heparin after endocytosis. Knockdown of TMEM184A eliminated the physiological responses to heparin, including effects on ERK pathway activity and BrdU incorporation. Isolated GFP-TMEM184A binds heparin, and overexpression results in additional heparin uptake. Together, these data support the identification of TMEM184A as a heparin receptor in vascular cells.
Zhonghua Yi Xue Za Zhi. May, 2016 | Pubmed ID: 27180749
To explore the renoprotective effects of (-)-epigallocatechin-3-gallate (EGCG) and its potential mechanism in type 2 diabetic db/db mice.